308 related articles for article (PubMed ID: 30509048)
1. Low-grade fibromyxoid sarcoma of the extremities: a clinicopathologic study of 24 cases and review of the literature.
Sambri A; Righi A; Tuzzato G; Donati D; Bianchi G
Pol J Pathol; 2018; 69(3):219-225. PubMed ID: 30509048
[TBL] [Abstract][Full Text] [Related]
2. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
3. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
4. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
5. Primary Renal Hybrid Low-grade Fibromyxoid Sarcoma-Sclerosing Epithelioid Fibrosarcoma: An Unusual Pediatric Case With EWSR1-CREB3L1 Fusion.
Mok Y; Pang YH; Sanjeev JS; Kuick CH; Chang KT
Pediatr Dev Pathol; 2018; 21(6):574-579. PubMed ID: 29426275
[TBL] [Abstract][Full Text] [Related]
6. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
7. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases.
Prieto-Granada C; Zhang L; Chen HW; Sung YS; Agaram NP; Jungbluth AA; Antonescu CR
Genes Chromosomes Cancer; 2015 Jan; 54(1):28-38. PubMed ID: 25231134
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of the FUS-CREB3L2 translocation in low-grade fibromyxoid sarcoma.
Rose B; Tamvakopoulos GS; Dulay K; Pollock R; Skinner J; Briggs T; Cannon S
J Orthop Surg Res; 2011 Mar; 6():15. PubMed ID: 21406083
[TBL] [Abstract][Full Text] [Related]
9. Sclerosing epithelioid fibrosarcoma.
Patterson JW; Tchernev G; Chokoeva AA; Wick MR
Wien Med Wochenschr; 2017 Apr; 167(5-6):120-123. PubMed ID: 27631873
[TBL] [Abstract][Full Text] [Related]
10. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
11. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases.
Rekhi B; Deshmukh M; Jambhekar NA
Ann Diagn Pathol; 2011 Oct; 15(5):303-11. PubMed ID: 21550274
[TBL] [Abstract][Full Text] [Related]
12. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract][Full Text] [Related]
13. Deeply located low-grade fibromyxoid sarcoma with FUS-CREB3L2 gene fusion in a 5-year-old boy with review of literature.
Kurisaki-Arakawa A; Suehara Y; Arakawa A; Takagi T; Takahashi M; Mitani K; Kaneko K; Yao T; Saito T
Diagn Pathol; 2014 Sep; 9():163. PubMed ID: 25183312
[TBL] [Abstract][Full Text] [Related]
14. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
15. Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma.
Bartuma H; Möller E; Collin A; Domanski HA; Von Steyern FV; Mandahl N; Mertens F
Cancer Genet Cytogenet; 2010 Jun; 199(2):143-6. PubMed ID: 20471519
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2021 Nov; 34(6):1919-1928. PubMed ID: 34535876
[TBL] [Abstract][Full Text] [Related]
17. In-depth Genetic Analysis of Sclerosing Epithelioid Fibrosarcoma Reveals Recurrent Genomic Alterations and Potential Treatment Targets.
Arbajian E; Puls F; Antonescu CR; Amary F; Sciot R; Debiec-Rychter M; Sumathi VP; Järås M; Magnusson L; Nilsson J; Hofvander J; Mertens F
Clin Cancer Res; 2017 Dec; 23(23):7426-7434. PubMed ID: 28939748
[No Abstract] [Full Text] [Related]
18. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
19. [A hybrid lesion: Low-grade fibromyxoid sarcoma (LGFMS) and sclerosing epithelioid fibrosarcoma (SEF)].
Kesrouani C; Zemoura L; Trassard M; Laé M
Ann Pathol; 2016 Oct; 36(5):351-354. PubMed ID: 27641819
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene.
Mertens F; Fletcher CD; Antonescu CR; Coindre JM; Colecchia M; Domanski HA; Downs-Kelly E; Fisher C; Goldblum JR; Guillou L; Reid R; Rosai J; Sciot R; Mandahl N; Panagopoulos I
Lab Invest; 2005 Mar; 85(3):408-15. PubMed ID: 15640831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]